Jump to navigation

NCCN Continuing Education

Open menu

Contact Us
Log in
Register

NCCN CE Home
Education Catalog
NCCN.org
NCCN Guidelines®
NCCN Compendia®
FAQ

You are here

Home » Does Generic Imatinib Change the Treatment...

Does Generic Imatinib Change the Treatment Approach in CML?

Presentation

Return to Course Home
Return to Parent Home

Presentation

Course outline

Course progress

Not started
Slide Handout
Open/Close details
- Optional
Not started
Pre-test
Open/Close details
- Required
Not started
Presentation
Open/Close details
- Required
Not started
Immediate Post-test
Open/Close details
- Required
Not started
Evaluation
Open/Close details
- Required
Not started
Credit
Open/Close details
- Optional
Not started
Certificate
Open/Close details
- Optional

Expand / Minimize

Course navigation

About NCCN | NCCN Member Institutions | Patient Resources | NCCN Foundation | Privacy Policy | Legal Notices | Contact Us

3025 Chemical Road, Suite 100, Plymouth Meeting, PA 19462 • Phone: 215.690.0300 • Fax: 215.690.0280
Copyright © 2020 National Comprehensive Cancer Network, All Rights Reserved

Powered by the EthosCE Learning Management System, a continuing education LMS.